Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Ipca Laboratories Limited](/topic/$ipcalabbo)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ipcalabbo/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ipcalabbo/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% +33%  
**1 Month**: XXX% +40%  
**6 Months**: XXX% +22%  
**1 Year**: XXX% no change  
**1-Year High**: XXX% on 2024-11-03  
**1-Year Low**: XX% on 2024-12-24  

**Most Supportive Themes**
- **Partnership with BioSimilar Sciences:** (60%) Ipca Laboratories has entered into a technology transfer and joint development agreement with BioSimilar Sciences for a monoclonal antibody biosimilar.
- **Positive Press Release:** (20%) The company announced a technology transfer agreement with BioSimilar Sciences PR LLC for a monoclonal antibody biosimilar targeting a USD 4B+ US market.
  
**Most Critical Themes**
- **No immediate critical themes:** (0%)  There are no immediately critical themes.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | X        | X% |
| YouTube | XX       | X%  | XXX     | XX% | XX       | X% |
| Reddit  | X        | X%  | XX      | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | XX       | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Ipca Laboratories Limited

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +33%
1 Month: XXX% +40%
6 Months: XXX% +22%
1 Year: XXX% no change
1-Year High: XXX% on 2024-11-03
1-Year Low: XX% on 2024-12-24

Most Supportive Themes

  • Partnership with BioSimilar Sciences: (60%) Ipca Laboratories has entered into a technology transfer and joint development agreement with BioSimilar Sciences for a monoclonal antibody biosimilar.
  • Positive Press Release: (20%) The company announced a technology transfer agreement with BioSimilar Sciences PR LLC for a monoclonal antibody biosimilar targeting a USD 4B+ US market.

Most Critical Themes

  • No immediate critical themes: (0%) There are no immediately critical themes.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXX XX% X X%
YouTube XX X% XXX XX% XX X%
Reddit X X% XX X% X X%
Total XXX XX% XXX XX% XX X%
Ipca Laboratories Limited Sentiment
/topic/$ipcalabbo/sentiment